Salivary stimulation by prolonged release of pilocarpine in Sjögren’s syndrome.
Introduction: Prolonged drug delivery in the oral cavity offers many advantages, such as reducing adverse effects. Pilocarpine is an FDA-approved parasympathomimetic drug for the treatment of glandular hypofunction; however, its adverse effects limit its use. Objective: To evaluate the stimulation...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidad de Concepción.
2017-03-01
|
Series: | Journal of Oral Research |
Subjects: | |
Online Access: | http://www.joralres.com/index.php/JOR/article/view/312/297 |